{"database": "lobbying", "table": "lobbying_activities", "rows": [[633114, "f63a7faa-1acd-4020-9998-416e992d31e0", "Q2", "FIERCE, ISAKOWITZ & BLALOCK", 44812, "MOMENTA PHARMACEUTICALS, INC.", 2008, "second_quarter", "PHA", "Generic Biologics\nBiologics: S.623/H.R.1038: Access to Life Saving Medicines Act\nBiologics: H.R.5629: Pathway for Biosimilars Act\nBiologics: S.1695: Biologics Price Competition and Innovation Act of 2007\nDrug Safety as part of the Food and Drug Administration Globalization Act", "Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 20000, null, 0, 0, "2008-07-17T11:16:15-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["633114"], "units": {}, "query_ms": 0.2811240265145898, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}